Responses
Clinical/translational cancer immunotherapy
Original research
Efficacy and biomarker analysis of nivolumab plus gemcitabine and cisplatin in patients with unresectable or metastatic biliary tract cancers: results from a phase II study
Compose a Response to This Article
Other responses
No responses have been published for this article.
